eLifeMicrobiologyPeer-reviewed journal article
A biofilm-tropic Pseudomonas aeruginosa bacteriophage uses the exopolysaccharide Psl as receptor
Brenna Walton, Serena AbbondanteiD, Michaela Ellen MarshalliD, Justyna M. DobruchowskaiD, Amani Alvi, Larry A. GallagheriD, Nikhil Vallikat, Zhemin ZhangiD, Daniel J. WozniakiD, Edward W. YuiD, Geert‐Jan BoonsiD, Eric M. PearlmaniD, Arne RietschiD
Abstract
Bacteria in nature can exist in multicellular communities called biofilms. Biofilms also form in the course of many infections. Pseudomonas aeruginosa infections frequently involve biofilms, which contribute materially to the difficulty to treat these infections with antibiotic therapy. Many biofilm-related characteristics are controlled by the second messenger, cyclic-di-GMP, which is upregulated on surface contact. Among these factors is the exopolysaccharide Psl, which is a critically important component of the biofilm matrix. Here we describe the discovery of a P. aeruginosa bacteriophage, which we have called Clew-1, that directly binds to and uses Psl as a receptor. While this phage does not efficiently infect planktonically growing bacteria, it can disrupt P. aeruginosa biofilms and replicate in biofilm bacteria. We further demonstrate that the Clew-1 can reduce the bacterial burden in a mouse model of P. aeruginosa keratitis, which is characterized by the formation of a biofilm on the cornea. Due to its reliance on Psl for infection, Clew-1 does not actually form plaques on wild-type bacteria under standard in vitro conditions. This argues that our standard isolation procedures likely exclude bacteriophage that are adapted to using biofilm markers for infection. Importantly, the manner in which we isolated Clew-1 can be easily extended to other strains of P. aeruginosa and indeed other bacterial species, which will fuel the discovery of other biofilm-tropic bacteriophage and expand their therapeutic use.
- organism: mouse
- organism: bacteria (other)
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 7
- FWCI
- 2.28
- Field percentile
- top 14%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Small molecules with antibiofilm, antivirulence and antibiotic synergy activities against Pseudomonas aeruginosa.
Erik van Tilburg Bernardes, Laetitia Charron-Mazenod, … Shawn Lewenza·Antimicrobial Agents and ChemotherapyPeer-reviewed·May 1, 2017
- Complementary killing activities of Pbunavirus LS1 and Bruynoghevirus LUZ24 phages on planktonic and sessile Pseudomonas aeruginosa PAO1 derivatives
Maud Billaud, Clarisse Plantady, … Marie‐Agnès Petit·Antimicrobial Agents and ChemotherapyPeer-reviewed·Jul 23, 2025
- In vitro and in vivo evaluation of the biofilm-degrading Pseudomonas phage Motto, as a candidate for phage therapy
P. Manohar, B. Loh, … S. Leptihn·bioRxiv·Oct 12, 2022
- Potential application of phage therapy for prophylactic treatment against Pseudomonas aeruginosa biofilm Infections.
Aditi Gurkar, Deepak Balasubramanian, … Kalai Mathee·bioRxiv·Sep 9, 2018
- Targeted deletion of Pf prophages from diverse Pseudomonas aeruginosa isolates impacts quorum sensing and virulence traits
A. K. Schmidt, C. M. Schwartzkopf, … P. R. Secor·bioRxiv·Nov 19, 2023
- Pseudomonas aeruginosa PA5oct jumbo phage impacts planktonic and biofilm population and reduces its host virulence
T. Olszak, K. Danis-Wlodarczyk, … Z. Drulis-Kawa·bioRxiv·Jun 25, 2019